Natixis’s Cantel Medical Corporation CMD Stock Holding History

Natixis’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-138,900	Closed	-$6.14M	–	915
2020 Q2	$6.14M	Buy	+138,900	New	+$5.18M	0.05%	259
2018 Q4	–	Sell	-35,778	Closed	-$3.29M	–	870
2018 Q3	$3.29M	Buy	+35,778	New	+$3.41M	0.02%	434
2017 Q2	–	Sell	-3,979	Closed	-$319K	–	1034
2017 Q1	$319K	Buy	3,979 +45	+1%	+$3.58K	﹤0.01%	673
2016 Q4	$310K	Buy	+3,934	New	+$306K	﹤0.01%	623

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Natixis's CMD Position: Q3 2020 in Review

Natixis sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 138,900 shares — an estimated $6.14M sold.

Natixis first reported a position in CMD in Q4 2016 and held it in 4 quarters. The position peaked at $6.14M in Q2 2020. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

Natixis reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
Natixis sold 138,900 Cantel Medical Corporation shares in Q3 2020, an estimated $6.14M.
Natixis first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 4 quarters.
Natixis's Cantel Medical Corporation position peaked at $6.14M in Q2 2020.
196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Natixis's 13F filing for Q3 2020, filed 12 Nov 2020.